Article Versions Notes

Jeong H, Jeong JH, Kim K-P, Lee SS, Oh DW, Park DH, Song TJ, Park Y, Hong S-M, Ryoo B-Y, et al. Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin. Cancers. 2021; 13(2):161. https://doi.org/10.3390/cancers13020161

Jeong, Hyehyun, Jae Ho Jeong, Kyu-Pyo Kim, Sang Soo Lee, Dong Wook Oh, Do Hyun Park, Tae Jun Song, Yangsoon Park, Seung-Mo Hong, Baek-Yeol Ryoo, and et al. 2021. "Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin" Cancers 13, no. 2: 161. https://doi.org/10.3390/cancers13020161

Jeong, H., Jeong, J. H., Kim, K.-P., Lee, S. S., Oh, D. W., Park, D. H., Song, T. J., Park, Y., Hong, S.-M., Ryoo, B.-Y., & Yoo, C. (2021). Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin. Cancers, 13(2), 161. https://doi.org/10.3390/cancers13020161